NASDAQ: JYNT
Joint Corp Stock

$11.02+0.00 (+0%)
Updated Jun 18, 2025
JYNT Price
$11.02
Fair Value Price
$5.88
Market Cap
$168.64M
52 Week Low
$9.58
52 Week High
$15.32
P/E
-19x
P/B
8.47x
P/S
2.16x
PEG
N/A
Dividend Yield
N/A
Revenue
$87.98M
Earnings
-$8.68M
Gross Margin
86.6%
Operating Margin
-9.53%
Profit Margin
-9.9%
Debt to Equity
2.88
Operating Cash Flow
$3M
Beta
1.33
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

JYNT Overview

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine JYNT's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Care Facility

Industry Rating
A
JYNT
Ranked
#33 of 42

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$9.34A
$14.44A
$3.99A
View Top Medical Care Facility Stocks

Be the first to know about important JYNT news, forecast changes, insider trades & much more!

JYNT News

Overview

Due Diligence Score

Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how JYNT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

JYNT ($11.02) is overvalued by 87.53% relative to our estimate of its Fair Value price of $5.88 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
JYNT ($11.02) is not significantly undervalued (87.53%) relative to our estimate of its Fair Value price of $5.88 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
JYNT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more JYNT due diligence checks available for Premium users.

Valuation

JYNT fair value

Fair Value of JYNT stock based on Discounted Cash Flow (DCF)

Price
$11.02
Fair Value
$5.88
Overvalued by
87.53%
JYNT ($11.02) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
JYNT ($11.02) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
JYNT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

JYNT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-19x
Industry
16.49x
Market
28.67x

JYNT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
8.47x
Industry
4.56x
JYNT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

JYNT's financial health

Profit margin

Revenue
$13.1M
Net Income
$801.4k
Profit Margin
6.1%
JYNT's Earnings (EBIT) of -$8.38M... subscribe to Premium to read more.
Interest Coverage Financials
JYNT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$77.2M
Liabilities
$57.3M
Debt to equity
2.88
JYNT's short-term assets ($67.83M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
JYNT's short-term assets ($67.83M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
JYNT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
JYNT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.7M
Investing
-$291.4k
Financing
$893.2k
JYNT's operating cash flow ($2.90M)... subscribe to Premium to read more.
Debt Coverage Financials

JYNT vs Medical Care Facility Stocks

TickerZen RatingMarket Cap1d %P/EP/B
JYNTC$168.64M0.00%-19.00x8.47x
DCGOD$160.55M+1.25%-162.00x0.52x
BTMDA$201.95M+1.53%5.70x-2.24x
TOIC$212.38M+1.71%-0.00x41.90x
MODVF$51.96M+11.38%-0.22x-0.59x

Joint Stock FAQ

What is Joint's quote symbol?

(NASDAQ: JYNT) Joint trades on the NASDAQ under the ticker symbol JYNT. Joint stock quotes can also be displayed as NASDAQ: JYNT.

If you're new to stock investing, here's how to buy Joint stock.

What is the 52 week high and low for Joint (NASDAQ: JYNT)?

(NASDAQ: JYNT) Joint's 52-week high was $15.32, and its 52-week low was $9.58. It is currently -28.04% from its 52-week high and 15.03% from its 52-week low.

How much is Joint stock worth today?

(NASDAQ: JYNT) Joint currently has 15,302,772 outstanding shares. With Joint stock trading at $11.02 per share, the total value of Joint stock (market capitalization) is $168.64M.

Joint stock was originally listed at a price of $6.58 in Nov 11, 2014. If you had invested in Joint stock at $6.58, your return over the last 10 years would have been 67.48%, for an annualized return of 5.29% (not including any dividends or dividend reinvestments).

How much is Joint's stock price per share?

(NASDAQ: JYNT) Joint stock price per share is $11.02 today (as of Jun 18, 2025).

What is Joint's Market Cap?

(NASDAQ: JYNT) Joint's market cap is $168.64M, as of Jun 19, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Joint's market cap is calculated by multiplying JYNT's current stock price of $11.02 by JYNT's total outstanding shares of 15,302,772.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.